These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1943183)

  • 1. Cardiac preservation in patients undergoing transplantation. A clinical trial comparing University of Wisconsin solution and Stanford solution.
    Stein DG; Drinkwater DC; Laks H; Permut LC; Sangwan S; Chait HI; Child JS; Bhuta S
    J Thorac Cardiovasc Surg; 1991 Nov; 102(5):657-65. PubMed ID: 1943183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of University of Wisconsin solution on clinical heart transplantation. A comparison with Stanford solution for extended preservation.
    Stringham JC; Love RB; Welter D; Canver CC; Mentzer RM
    Circulation; 1998 Nov; 98(19 Suppl):II157-61; discussion II162. PubMed ID: 9852898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial.
    Jeevanandam V; Barr ML; Auteri JS; Sanchez JA; Fong J; Schenkel FA; Marboe CC; Michler RE; Smith CR; Rose EA
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):194-8; discussion 198-9. PubMed ID: 1735983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. University of Wisconsin solution versus Stanford cardioplegic solution and the development of cardiac allograft vasculopathy.
    Drinkwater DC; Rudis E; Laks H; Ziv E; Marino J; Stein D; Ardehali A; Aharon A; Moriguchi J; Kobashigawa J
    J Heart Lung Transplant; 1995; 14(5):891-6. PubMed ID: 8800725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved heart preservation with UW preservation solution.
    Swanson DK; Pasaoglu I; Berkoff HA; Southard JA; Hegge JO
    J Heart Transplant; 1988; 7(6):456-67. PubMed ID: 3145337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioplegia for heart transplantation: unmodified UW solution compared with Stanford solution.
    Gott JP; Brown WM; Pan-Chih ; Dorsey LM; Walker B; Guyton RA
    J Heart Lung Transplant; 1992; 11(2 Pt 1):353-61; discussion 362. PubMed ID: 1576141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical heart transplantation with extended preservation time (>5 hours): experience with University of Wisconsin solution.
    Kur F; Beiras-Fernandez A; Meiser B; Uberfuhr P; Reichart B
    Transplant Proc; 2009; 41(6):2247-9. PubMed ID: 19715888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. University of Wisconsin solution provides superior myocardial preservation compared with Stanford cardioplegic solution.
    Aziz S; Tada Y; Jaffery S; Mori Y; Reichenbach DD; Gronka R; Kushmerick M; Verrier ED
    J Heart Lung Transplant; 1994; 13(6):1099-108. PubMed ID: 7865517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia.
    Boku N; Tanoue Y; Kajihara N; Eto M; Masuda M; Morita S
    J Heart Lung Transplant; 2006 Feb; 25(2):219-25. PubMed ID: 16446224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation.
    George TJ; Arnaoutakis GJ; Baumgartner WA; Shah AS; Conte JV
    J Heart Lung Transplant; 2011 Sep; 30(9):1033-43. PubMed ID: 21683620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac preservation by continuous perfusion of the University of Wisconsin solution.
    Jackson SJ; Pu LQ; Guerraty A; Symes JF
    Can J Surg; 1992 Apr; 35(2):165-8. PubMed ID: 1562926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of intracellular solutions for donor heart preservation.
    Hendry PJ; Labow RS; Keon WJ
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):667-73. PubMed ID: 8469000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular volumes and membrane permeability in rat hearts during prolonged hypothermic preservation with St Thomas and University of Wisconsin solutions.
    Askenasy N; Navon G
    J Mol Cell Cardiol; 1998 Jul; 30(7):1329-39. PubMed ID: 9710801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation.
    Rayya F; Harms J; Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):891-4. PubMed ID: 18555073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
    Okada K; Yamashita C; Okada M; Okada M
    J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial.
    Pearl JM; Drinkwater DC; Laks H; Capouya ER; Gates RN
    J Heart Lung Transplant; 1992; 11(6):1082-92. PubMed ID: 1457432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation.
    Meine MH; Zanotelli ML; Neumann J; Kiss G; de Jesus Grezzana T; Leipnitz I; Schlindwein ES; Fleck A; Gleisner AL; de Mello Brandão A; Marroni CA; Cantisani GP
    Transplant Proc; 2006; 38(6):1872-5. PubMed ID: 16908310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged hypothermic cardiac storage with University of Wisconsin solution. An assessment with human cell cultures.
    Fremes SE; Li RK; Weisel RD; Mickle DA; Tumiati LC
    J Thorac Cardiovasc Surg; 1991 Nov; 102(5):666-72. PubMed ID: 1943184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved viability and reduced apoptosis in sub-zero 21-hour preservation of transplanted rat hearts using anti-freeze proteins.
    Amir G; Rubinsky B; Basheer SY; Horowitz L; Jonathan L; Feinberg MS; Smolinsky AK; Lavee J
    J Heart Lung Transplant; 2005 Nov; 24(11):1915-29. PubMed ID: 16297800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.